Champions Oncology, Inc. (NASDAQ:CSBR) Q4 2024 Earnings Call Transcript July 18, 2024
Champions Oncology, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.16.
Operator: Greetings. Welcome to Champions Oncology’s Fourth Quarter Fiscal Year 2024 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is...
